Arrhythmias & EP
From the Journals
Cardiorespiratory fitness may alter AFib ablation outcomes
Patients with the highest level of cardiorespiratory fitness at baseline had the best outcomes after atrial fibrillation ablation in a single-...
Guidelines
AHA on cannabis: No evidence of heart benefits, but potential harms
The American Heart Association emphasizes potential risks and lack of benefits of cannabis for cardiovascular health.
Feature
How three cardiac procedures changed in the COVID era
From the Journals
SCD-HeFT 10-year results: Primary-prevention ICD insights in nonischemic heart failure
The trial’s most recent results add to ongoing controversy – fueled by DANISH and other studies – about whether primary-prevention ICDs prolong...
From the Journals
AHA statement addresses genetic testing for CVD
The American Heart Association issued a scientific statement that provides recommendations for conducting genetic testing for cardiovascular...
From the Journals
New oral anticoagulants drive ACC consensus on bleeding
A new consensus document from the American College of Cardiology updates management of acute bleeding in patients on oral anticoagulants.
From the Journals
How to reboot elective CV procedures after COVID-19 lockdown
From the Journals
COVID-19: ‘dramatic’ surge in out-of-hospital cardiac arrests in NYC
At the height of the COVID-19 pandemic in New York City, first responders faced nearly triple the number of calls for cardiac arrest compared with...
From the Journals
LAA Closure noninferior to DOACs to prevent AF-related events
Left atrial appendage occlusion offers nondrug alternative to stroke prevention for atrial fibrillation patients.
Commentary
Preventing arrhythmias and QTc prolongation in COVID-19 patients on psychotropics
Psychotropics associated with QTc interval prolongation should be discontinued (or substituted with a low-risk agent) if a patient presents with...
Conference Coverage
Smart phones boosted compliance for cardiac device data transmission